Molecular markers of endometrial carcinoma detected in uterine aspirates.
about
Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like VesiclesMammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.Genome-wide association study for posthitis in the free-living population of European bison (Bison bonasus)First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneum.Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients.Discoidin domain receptor tyrosine kinases: new players in cancer progressionBiomarkers in endometrial cancer: Possible clinical applications (Review)Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols.Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies.Differential gene expression of the key signalling pathway in para-carcinoma, carcinoma and relapse human pancreatic cancer.PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer.Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers.Putative tumor suppression function of SIRT6 in endometrial cancer.Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs.IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.Molecular diagnosis of endometrial cancer from uterine aspirates.Advances in endometrial cancer protein biomarkers for use in the clinic.Clearance of a persistent picornavirus infection is associated with enhanced pro-apoptotic and cellular immune responses.FBLN-4 and BCRP genes as two prognostic markers are downregulated in breast cancer tissue.Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma.Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine.Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients.Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signalingmiR-199b-5p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1
P2860
Q28550734-10AC72A8-B1F4-4B4B-9302-94E9CA152D4AQ34664059-369ECB49-805F-46E3-8217-C6AA1BA28FF0Q34998209-B3FFA9FE-968D-47F2-9B9F-A2AC6EDD4872Q35840697-D8D449D3-E72D-403B-A8E4-11444629E00DQ35883559-E791237A-A072-444D-939E-A821E7D0B634Q35957518-C5F33990-999B-47CB-98CB-5C2427ED5FFFQ36084326-6510F9F2-2A61-44D6-B790-F3394B2FE792Q36250030-C0ED1A0A-7AE5-44E1-A45E-B95A4443599EQ36502473-D860BF18-2D14-4E57-A379-CF69A1676652Q37018155-5F3921CF-5096-4790-9086-F9E5E1A03281Q37457884-FA0C774E-A718-4DD0-ADC7-DC98844C0BDAQ37636282-194AA348-8D19-41A0-AAE1-AA8F0917C152Q37686441-49B7C3A3-5BE5-4418-AFF3-2AA4489233F6Q38484647-E1F1AC46-DA90-4EBF-BD09-04DE7B8E4521Q38599066-E5A3D98B-B8EE-4574-A987-C31C60514031Q38825241-533B9B73-BDAE-4F88-B364-04C5DF6CEB30Q38852078-63CAFDE3-5690-48E9-AD18-FA3665827F28Q39317584-A55D6E58-1C92-457B-86B9-8F014FA2D09FQ41472551-C4FA6EF5-C672-43A2-B5E0-8561DDA6B98CQ42109826-159F2D82-29D7-46DF-AF8E-9DE344D849CEQ44593249-C1637904-7F88-4444-935D-0B49ECF83397Q47355920-10BC3344-780B-45A8-855D-460A06A7F0F4Q47563315-79589417-6275-4A8C-B59C-261505010549Q50850498-DA30003B-FD90-4879-8574-93BA7074C2D2Q54981868-4F65BA32-FB30-4615-ABEF-EE339B841019Q55020802-1AB22286-AC65-4D0A-88AD-00632E08C9E8Q55093007-D321A342-AF79-4B94-B98D-46FEDA49AC4CQ57116175-9982482E-925A-4567-9FD5-996F1F1C5FAAQ58802696-1E14BE32-43BD-4BD8-B41E-EE89F85F6637
P2860
Molecular markers of endometrial carcinoma detected in uterine aspirates.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@ast
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@en
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@nl
type
label
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@ast
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@en
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@nl
prefLabel
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@ast
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@en
Molecular markers of endometrial carcinoma detected in uterine aspirates.
@nl
P2093
P2860
P50
P356
P1476
Molecular markers of endometrial carcinoma detected in uterine aspirates
@en
P2093
Alicia Ortega
Cristina Perez
Elisabet Rosell
Fernando Eyzaguirre
Jaume Reventos
Jesus Gregorio
Marina Rigau
Marta Llaurado
Marta Monge
P2860
P304
P356
10.1002/IJC.25901
P50
P577
2011-04-08T00:00:00Z